A newantibiotic, sorangicin, was isolated from the culture supernatant of the myxobacterium, Sorangium {Polyangium) cellulosum strain So eel2. It is a macrocyclic lactone carbonic acid and is produced in two structural variants, sorangicins A and B. In addition small quantities of the respective glycosides, sorangiosids A and B, maybe found. The antibiotic acts mainly against Gram-positive bacteria, including mycobacteria, with MICvalues between 0.01 and 0.1^g/ml, but at higher concentrations (MIC 3~3O A*g/ml) Gram-negatives are also inhibited. Yeasts and moldsare completely resistant. The newantibiotic is a specific inhibitor of eubacterial RNApolymerase which it blocks, however, only if added before RNA polymerization has started.
During our screening program for antibiotics from myxobacteria the culture supernatant of a strain of Sorangium cellulosum showed antibiotic activity against Gram-positive bacteria. Whenisolated and chemically characterized, the active complex turned out to consist of 4 compounds of a novel structure, macrocyclic lactone carbonic acids (Fig. 1 ). They were named sorangicins A and B, and sorangiosids A and B; the latter are glycosides of the former. In this paper we describe the production and some chemical and biological properties of the new antibiotics, while the structure elucidation is described elsewhere1*^.
Fermentation of the Antibiotics The producing organism, Sorangium {Polyangium) cellulosum strain So cel2, was isolated in 1978 from a soil sample from Xcaret, Mexico. It could be cultivated in MD1liquid medium (MDI l.m.)3) : peptone from casein, tryptically digested 0.3%, MgSO4-7H2O0.2%, CaCl2-2H2O 0.05%, pH 7.2, provided a suitable carbohydrate, e.g. 0.1 % glucose or starch was added. Another useful medium was CK6 liquid medium (CK6 l.m.)3) : MgSO4-7H2O 0.15%, CaCl2-2H2O 0.15%, FeCl3-7H2O 8 mg/ liter, KNO3 0.2%, K2HPO4 0.025%, glucose 0.5 %.
In MDI l.m., So cel2 grew homogeneously, whereas in CK6 l.m. there were always lumps besides single cells in the culture liquid. Addition of peptone in low concentrations (0.05 %) improved homogeneous growth in CK6 l.m. The influence of the peptone concentration on growth and antibiotic production, as determined from the diameter of the inhibition zone with Staphylococcus aureus as an indicator organism, is shown in Table 1 . Best production occurred at low peptone concentrations. Anincrease in the glucose content led to a rapid drop of the pH to below 6, and growth and production became inhibited. Fermentations were consequently performed in CK6l.m. supplemented with 0.05% peptone. Bioreactors from Giovanola Freres, Manthey, Switzerland, with a volume of 700 liters were used. They were equipped with turbine impellers and inoculated with 10 %from an earlier fermentor culture. The aeration and stirring rates were adjusted to 0.012 vol/vol/minute and 100 rpm, respectively. The pO2 decreased slowly to about 20% during the first 50 hours of fermentation. It was kept at this value during the next 40 hours. The pH was not regulated and decreased from 7.3 at the beginning to 6.7 after 35 hours. Then it rose again to 7.3 at the end of the fermentation. At harvest time, the cells were separated from the culture broth by centrifugation. The antibiotic yield of the first fermentations was only about 1 mgper liter.
Isolation of the Antibiotics The cell free supernatant (700 liters) was extracted in a counter current device with ethyl acetate. Vacuumevaporation of the solvent resulted in an oily residue (13.5 g) containing approximately 700 mg of sorangicin A. By distribution between methanol and heptane, the antibiotic was concentrated 2-fold in the methanolic phase. This material was partitioned between ethyl ether and 12% aqueous ammonia.After evaporation of the ammonia from the aqueous phase and acidification, the crude antibiotic (2.7 g) could be re-extracted with dichloromethane. methane, then the buffer was removed by washing with 1 %formic acid. The first two fractions contained small amounts of the glycosides, sorangiosids A and B2). Fraction 3 yielded 400 mg of crystalline sorangicin A1*25 (Fig. 1) , and the last fraction 43 mg of sorangicin B as a syrup2) (Fig. 1) . As in the example above, sorangicin A also was the main componentin all other fermentations, Ci/mol) into perchloric acid insoluble material. At the time indicated by the arrow the antibiotic (0.05 z^g/ml) was added to the experimental culture (O). Control (#) without sorangicin A. Biological Activity Sorangicins A and B were active mainly against Gram-positive bacteria, although at higher concentrations they also acted against Gram-negatives (Tables 2 and 3 ). Yeasts and fungi were completely resistant. The glycosides of the sorangicins, the sorangiosids, had only poor activities. Curiously, several myxobacteria including strains of *$. cellulosum were very sensitive to sorangicin A, but the producing strain was influenced by the antibiotic only at very high concentrations (50^g/ml).
The effect of sorangicin A on the syntheses of biomacromolecules was tested with S. aureus as described recently4). RNAand protein synthesis were inhibited 3 and 10 minutes, respectively, after the addition of 0.05^g/ml sorangicin A, and thymidine incorporation into DNAnot before 25 minutes (Figs. 5, 6 and 7) . These data suggested that RNAsynthesis was the primary target of sorangicin A. This was confirmed by in vitro experiments with RNApolymerase from Escherichia coli (E.G. 2.7.7.6. ; Boehringer, Mannheim). With 0.02^g/ml sorangicin A, a 50% inhibition of the enzyme activity JAN. 1987 was observed, and total inhibition occurred with 0.1 jug/ml (Fig.  8 ).
In contrast, RNApolymerase II from wheat germ (Miles Laboratories, Elkart, Indiana) was not inhibited by 50 /«g/ml sorangicin A.
The kinetics of uridine incorporation into RNA by E. coli polymerase4) is shown in Fig. 9 . The mixture was divided 4 minutes after the reaction had been started. To one half, 0.1^g/ml sorangicin A was added, and to the other an equivalent volume of methanol. As can be seen, the RNApolymerization was no longer inhibited whensorangicin A was added after the reaction had been initiated.
Discussion
The sorangicins are macrocyclic antibiotics of a novel type (Fig. 1) . They are inhibitory for eubacteria only, and Gram-positives including mycobacteria are particularly sensitive (Tables 2 and  3) . Gram-negatives usually react, too, but at much higher concentrations. A remarkable exception are the myxobacteria themselves which are very sensitive to the sorangicins. This is reminiscent of their behavior towards another inhibitor of RNAsynthesis, actinomycin D, to which they also are muchmore sensitive than most Gram-negatives5). The unusual sensitivity may, however, be connected with penetration rather than the mechanism of action, which in the details differs substantially for the two inhibitors, anyway. Eukaryotic cells are completely resistant. Of the two structure variants of sorangicin, compoundB appears to be slightly more efficient, while by glycosylation the potency of both is reduced drastically. The primary site of action of sorangicin A, the only structure variant investigated in this respect, appears to be RNAsynthesis in S. aureus (Figs. 5, 6 and 7) . Experiments with isolated RNApolymerase from E. coli confirmed that this enzyme is indeed the molecular target. The high in vitro sensitivity of the enzyme further suggests that the observed resistance of Gram-negatives may be due to impeded penetration. Kinetic studies clearly demonstrated that the E. coli enzyme is no longer inhibited by sorangicin A after RNApolymerization has been initiated. This is the same kind of interference known for rifampicin6>7) but it differs from that of corallopyronin and myxopyronin, two other inhibitors of bacterial RNAsynthesis recently isolated by us from myxobacteria4 '8) .
